Status: closed
Merck Sharp & Dohme Corp. (Vioxx)
Defendant: Merck Sharp & Dohme Corp.
Consumers who purchased Vioxx before October 1, 2004 may be eligible for up to $50 cash or reimbursement of actual out-of-pocket costs. The company reached a settlement over allegations of falsely advertising the greater benefits of Vioxx in comparison to less expensive pain medicines.